Literature DB >> 21164135

Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia.

Oumei Cheng1, Robert P Ostrowski, Bihua Wu, Wenwu Liu, Chunhua Chen, John H Zhang.   

Abstract

BACKGROUND AND
PURPOSE: Hyperbaric oxygen (HBO) preconditioning (PC) allows brain protection against transient global ischemia. In the present study, we hypothesize that the mechanism of HBO-PC involves the induction of cyclooxygenase-2 (COX-2) in cerebral tissues before ischemia, which leads to a suppression of COX-2 and its downstream targets after global ischemic insult.
METHODS: One hundred twenty-nine male Sprague Dawley rats (body weight 280-300 grams) were allocated to the naive control group and the sham operation group, and 3 groups of animals were subjected to 15-minute 4-vessel occlusion: untreated, preconditioned with HBO 2.5 atmospheres absolutes for 1 hour daily for 5 days, preconditioned as mentioned and administered with COX-2 inhibitor NS-398 (1 mg/kg body weight intraperitoneal) before each preconditioning session, and normal rats preconditioned with HBO without ischemia. The mortality, the incidence of seizures, and T-maze scores were recorded. The quantitative cell count in Nissl stain and TUNEL was conducted on day 7 after ischemia. The brain expression of COX-2 was analyzed with Western blotting and immunofluorescence staining.
RESULTS: HBO-PC increased the number of surviving neurons in the Cornu Ammonis area 1, which was associated with the reduced COX-2 expression in the hippocampus and in the cerebral cortex at 1 and 3 days after ischemia. HBO-PC improved functional performance and tended to decrease mortality and the frequency of seizures. These beneficial effects of HBO-PC were abolished by the COX-2 selective inhibitor NS-398.
CONCLUSIONS: HBO-PC reduced COX-2 expression and provided brain protection after global ischemia. Administration of COX-2 inhibitor with HBO before ischemia abolished preconditioning effect, thereby implicating COX-2 as a mediator of HBO-PC in the ischemic brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164135      PMCID: PMC3026922          DOI: 10.1161/STROKEAHA.110.604421

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

1.  Preferential conditions for and possible mechanisms of induction of ischemic tolerance by repeated hyperbaric oxygenation in gerbil hippocampus.

Authors:  K Wada; T Miyazawa; N Nomura; N Tsuzuki; H Nawashiro; K Shima
Journal:  Neurosurgery       Date:  2001-07       Impact factor: 4.654

2.  One-stage anterior approach for four-vessel occlusion in rat.

Authors:  Mitsuo Yamaguchi; John W Calvert; Gen Kusaka; John H Zhang
Journal:  Stroke       Date:  2005-09-15       Impact factor: 7.914

3.  Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats.

Authors:  Taku Sugawara; Anders Lewén; Nobuo Noshita; Yvan Gasche; Pak H Chan
Journal:  J Neurotrauma       Date:  2002-01       Impact factor: 5.269

4.  Expression of cyclooxygenase-2 in astrocytes of human brain after global ischemia.

Authors:  D Maślińska; R Woźniak; A Kaliszek; I Modelska
Journal:  Folia Neuropathol       Date:  1999       Impact factor: 2.038

5.  Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice.

Authors:  Tsutomu Sasaki; Kazuo Kitagawa; Kanato Yamagata; Takako Takemiya; Shigeru Tanaka; Emi Omura-Matsuoka; Shiro Sugiura; Masayasu Matsumoto; Masatsugu Hori
Journal:  J Cereb Blood Flow Metab       Date:  2004-01       Impact factor: 6.200

6.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Delayed hippocampal damage in humans following cardiorespiratory arrest.

Authors:  C K Petito; E Feldmann; W A Pulsinelli; F Plum
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

8.  Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB.

Authors:  O Cheng; R P Ostrowski; W Liu; J H Zhang
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

9.  Temporal profile of neuronal damage in a model of transient forebrain ischemia.

Authors:  W A Pulsinelli; J B Brierley; F Plum
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

10.  Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

Authors:  S Nogawa; F Zhang; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

View more
  42 in total

Review 1.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

2.  Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats.

Authors:  Prativa Sherchan; Tim Lekic; Hidenori Suzuki; Yu Hasegawa; William Rolland; Kamil Duris; Yan Zhan; Jiping Tang; John H Zhang
Journal:  J Neurotrauma       Date:  2011-10-20       Impact factor: 5.269

Review 3.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

4.  Neuroprotective potential of exercise preconditioning in stroke.

Authors:  Mohammad Rashedul Islam; Michael F Young; Christiane D Wrann
Journal:  Cond Med       Date:  2017

5.  Hyperbaric oxygen preconditioning protects skin from UV-A damage.

Authors:  Ashley M Fuller; Charles Giardina; Lawrence E Hightower; George A Perdrizet; Cassandra A Tierney
Journal:  Cell Stress Chaperones       Date:  2012-08-03       Impact factor: 3.667

6.  Osteopontin Mediates Hyperbaric Oxygen Preconditioning-Induced Neuroprotection Against Ischemic Stroke.

Authors:  Sheng-Li Hu; Yu-Xing Huang; Rong Hu; Fei Li; Hua Feng
Journal:  Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.590

Review 7.  Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.

Authors:  David Brand; Rajiv R Ratan
Journal:  Transl Stroke Res       Date:  2013-01-08       Impact factor: 6.829

8.  A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Authors:  Grant M Liska; Trenton Lippert; Eleonora Russo; Norton Nieves; Cesar V Borlongan
Journal:  Cond Med       Date:  2018-06

9.  Should the STAIR criteria be modified for preconditioning studies?

Authors:  Michael M Wang; Guohua Xi; Richard F Keep
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

10.  Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice.

Authors:  Rajeev Verma; Avijeet Chopra; Charles Giardina; Venkata Sabbisetti; Joan A Smyth; Lawrence E Hightower; George A Perdrizet
Journal:  Cell Stress Chaperones       Date:  2015-02-04       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.